Programmed Cell Death (PD) Inhibitors Dominate Head and Neck Cancer Therapeutics Market with a share of 42.1% in 2024

By -

A new report from Industry Experts Inc, on "Head and Neck Cancer Therapeutics," is introduced. According to this global market research report, the global market for Head and Neck Cancer Therapeutics is estimated at US$1.7 billion in 2024 and is anticipated to post a CAGR of 9.4% during the 2024-2030 analysis period and stand at a projected US$3 billion by 2030.

The head and neck cancer market is primarily driven by increased research and development, which leads to the approval of new drugs, particularly for immunotherapy, targeted therapy, and chemotherapy. Healthcare providers are developing effective treatment options for several types of head and neck cancers, as evidenced by FDA approvals for drugs like Cetuximab and Docetaxel. Market growth is also driven by the rising incidence of HPV infections and increased consumption of alcohol and tobacco, which contribute to the prevalence of head and neck cancers.

Programmed Cell Death (PD) Inhibitors dominate the head and neck cancer therapeutics market with an estimated share of 42.1% in 2024 and is projected to be the fastest-growing therapeutic class, with a CAGR of 10.5% during the analysis period 2024-2030. These inhibitors have shown promising results in improving survival rates and extending progression-free survival, especially in patients with advanced or recurrent cancer.


The market for head and neck cancer therapeutics analyzed in this report on a global basis covering all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

The study analyzes the global market for head and neck cancer therapeutics analyzed with respect to Drug Class – Programmed Cell Death (PD) Inhibitors, Microtubule Inhibitors and Epidermal Growth Factor Receptor (EGFR) Inhibitors; Treatment Type – Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery; Route of Administration – Injectable and Oral; and End-User – Hospitals, Specialty Clinics and Ambulatory Surgical Centers (ASCs).

About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

Comments

Post a Comment

Popular posts from this blog

Use of Antimony in Lead Acid Batteries, Flame Retardants Propelling Demand, Projected to Reach US$3.5 billion by 2030

By -
Image
Industry Experts, Inc., has released its latest report on " Antinomy ", which projects the demand for this semi-metallic element to reach in excess of US$3.5 billion by 2030 from an estimated US$2.5 billion in 2024 at a CAGR of 6.2% between the two years. Some of the factors instrumental in driving demand for Antimony include its widespread use in flame retardants (in pentoxide & trioxide compound forms) and as an alloying agent with lead in lead acid batteries to increase the strength, corrosion resistance and castability of battery grids. The primary applications of flame retardants include protecting construction materials, plastics, textiles and electrical & electronic components against fire hazards. Asia-Pacific leads the demand for Antimony on a global basis and is also anticipated to be the fastest growing region. China’s dominance as the number one producer and consumer of Antimony has remained unchallenged for some time now and would continue i
Read more

Alzheimer's Drugs Market to Grow Rapidly by about 10% CAGR During 2024-2030 and Touch $5 billion by 2030

By -
Image
A new report from Industry Experts Inc, on " Alzheimer’s Drugs ", is introduced. According to this study, global market for Alzheimer’s Drugs will likely maintain a robust CAGR of 9.9% during the 2024-2030 analysis period and reach a projected US$9.2 billion by 2030 from an estimated US$5.2 billion in 2024. The rising prevalence of Alzheimer's disease, driven mainly by the aging population, is leading to the expansion of the Alzheimer's drugs market. With the increase in life expectancy, especially in developed countries, there is a growing number of people at risk for Alzheimer's disease, leading to a larger group of potential patients. Innovations in drug development, such as medications aimed at the root cause of illnesses, combined with increased awareness and early diagnoses, further drive this market growth. North America leads the Alzheimer's drugs market with an estimated share of 38.9% in 2024, driven by a high prevalence of the disease,
Read more

Industry Experts, Inc. Projects Global Market for Specialty Cellulose to Reach 2 Million Metric Tons by 2030 Driven by Cellulose Ethers and MCC

By -
Image
Industry Experts, Inc unveiled the new global market research report on Specialty Cellulose. As per this new report entitled " Specialty Cellulose – A Global Market Overview ", Cellulose Ethers grade would emerge the largest market for Specialty Cellulose globally, occupying a volume share of 34.5% estimated in 2024 while the segment is also anticipated to grow faster to keep the largest chunk of the pie intact through 2030. Demand growth for Specialty Cellulose is expected to accelerate at a moderate pace, driven by the increasing popularity of bio-based materials across various end-use markets. This growth will be led by cellulose ethers and microcrystalline cellulose (MCC), supported by positive long-term trends in the pharmaceutical, food, and construction industries, particularly in emerging countries such as China and India. Conversely, demand for cellulose acetate is projected to remain flat during the forecast period. This is due to a decline in consumption linked to
Read more